Cargando…

O:2-CRM(197) Conjugates against Salmonella Paratyphi A

Enteric fevers remain a common and serious disease, affecting mainly children and adolescents in developing countries. Salmonella enterica serovar Typhi was believed to cause most enteric fever episodes, but several recent reports have shown an increasing incidence of S. Paratyphi A, encouraging the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Micoli, Francesca, Rondini, Simona, Gavini, Massimiliano, Lanzilao, Luisa, Medaglini, Donata, Saul, Allan, Martin, Laura B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492368/ https://www.ncbi.nlm.nih.gov/pubmed/23144798 http://dx.doi.org/10.1371/journal.pone.0047039

Ejemplares similares

Immunogenicity of a Bivalent Adjuvanted Glycoconjugate Vaccine against Salmonella Typhimurium and Salmonella Enteritidis
por: Fiorino, Fabio, et al.
Publicado: (2017)

Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease
por: Lanzilao, Luisa, et al.
Publicado: (2015)

Safety, Immunogenicity and Dose Ranging of a New Vi-CRM(197) Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults
por: van Damme, Pierre, et al.
Publicado: (2011)

Relationship between Antibody Susceptibility and Lipopolysaccharide O-Antigen Characteristics of Invasive and Gastrointestinal Nontyphoidal Salmonellae Isolates from Kenya
por: Onsare, Robert S., et al.
Publicado: (2015)

Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM(197) conjugate vaccine
por: Micoli, Francesca, et al.
Publicado: (2020)

Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella
por: Micoli, Francesca, et al.
Publicado: (2018)

Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM(197) as carrier protein
por: Stefanetti, G., et al.
Publicado: (2020)

Site‐Specific Multi‐Functionalization of the Carrier Protein CRM(197) by Disulfide Rebridging for Conjugate Vaccine Development
por: Trattnig, Nino, et al.
Publicado: (2022)

Novel Simple Conjugation Chemistries for Decoration of GMMA with Heterologous Antigens
por: Di Benedetto, Roberta, et al.
Publicado: (2021)

Investigating the Deoxyribonuclease Activity of CRM197 with Site-Directed Mutagenesis
por: Bravo-Bautista, Nathalie, et al.
Publicado: (2019)

Comparison of Immune Responses to Two Quadrivalent Meningococcal Conjugate Vaccines (CRM197 and Diphtheria Toxoid) in Healthy Adults
por: Kim, Han Wool, et al.
Publicado: (2019)

Structural and immunological characterization of E. coli derived recombinant CRM(197) protein used as carrier in conjugate vaccines
por: Mishra, Ravi P.N., et al.
Publicado: (2018)

Salmonella Paratyphi Neck Abscess
por: Behera, Bijayini, et al.
Publicado: (2012)

Conjugation with 8-arm PEG and CRM(197) enhances the immunogenicity of SARS-CoV-2 ORF8 protein
por: Tang, Xiaozhao, et al.
Publicado: (2022)

Salmonella Paratyphi A Rates, Asia
por: Ochiai, R. Leon, et al.
Publicado: (2005)

Fluoroquinolone-resistant Salmonella Paratyphi A
por: Adachi, Takuya, et al.
Publicado: (2005)

Efficient recovery of recombinant CRM197 expressed as inclusion bodies in E.coli
por: Park, Ah-Reum, et al.
Publicado: (2018)

Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis
por: Rossi, Omar, et al.
Publicado: (2016)

Roles of Salmonella typhi and Salmonella paratyphi in Gallbladder Cancer Development
por: Shukla, Ratnakar, et al.
Publicado: (2021)

Diverse genome structures of Salmonella paratyphi C
por: Liu, Wei-Qiao, et al.
Publicado: (2007)

Salmonella Paratyphi B septicemia in a Neonate
por: Bhat, Pratibha, et al.
Publicado: (2013)

Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
por: Höbel, Sabrina, et al.
Publicado: (2011)

Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway
por: Edis, Bilge Ozerman, et al.
Publicado: (2018)

Monomeric crystal structure of the vaccine carrier protein CRM(197) and implications for vaccine development
por: Gallagher, D. Travis, et al.
Publicado: (2023)

Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide
por: Tobias, Joshua, et al.
Publicado: (2017)

CRM197-conjugated peptides vaccine of HCMV pp65 and gH induce maturation of DC and effective viral-specific T cell responses
por: Zhang, Shuyun, et al.
Publicado: (2023)

Production in Escherichia coli of recombinant COVID-19 spike protein fragments fused to CRM197
por: Bellone, Maria Laura, et al.
Publicado: (2021)

Aquariums as Reservoirs for Multidrug-resistant Salmonella Paratyphi B
por: Levings, Renee S., et al.
Publicado: (2006)

Genomic Surveillance of Salmonella Paratyphi A: Neglected No More?
por: Hooda, Yogesh, et al.
Publicado: (2023)

Molecular modeling provides insights into the loading of sialic acid‐containing antigens onto CRM(197): the role of chain flexibility in conjugation efficiency and glycoconjugate architecture
por: Kuttel, Michelle M., et al.
Publicado: (2021)

Design and production of conjugate vaccines against S. Paratyphi A using an O-linked glycosylation system in vivo
por: Sun, Peng, et al.
Publicado: (2018)

The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi
por: Arcuri, M., et al.
Publicado: (2017)

Salmonella paratyphi C: Genetic Divergence from Salmonella choleraesuis and Pathogenic Convergence with Salmonella typhi
por: Liu, Wei-Qiao, et al.
Publicado: (2009)

Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo(®)) in the context of treatment and prevention of invasive disease
por: Bröker, Michael, et al.
Publicado: (2011)

A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study
por: Xiong, An-Wen, et al.
Publicado: (2021)

Drug-resistant Salmonella enterica serotype paratyphi A in India.
por: Chandel, D S, et al.
Publicado: (2000)

Paratyphoid fever due to Salmonella enterica serotype Paratyphi A.
por: Kapil, A, et al.
Publicado: (1997)

Emergence of Multidrug-resistant Salmonella Paratyphi B dT(+), Canada
por: Mulvey, Michael R., et al.
Publicado: (2004)

Trends, Associations, and Antimicrobial Resistance of Salmonella Typhi and Paratyphi in Pakistan
por: Das, Jai K., et al.
Publicado: (2018)

Myositis associated with Salmonella paratyphi A bacteremia appears to be common
por: Harris, Adline, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_561q8itpj3eoivv8baa96558nu